Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.58008 | 59 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.47073 | 57 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.45405 | 57 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.31556 | 55 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.39297 | 57 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.74109 | 61 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.63464 | 59 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.43809 | 57 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.39724 | 56 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.42098 | 57 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.46364 | 57 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.41766 | 57 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.50342 | 58 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.45908 | 57 |